The initial public offering (IPO) of Senores Pharmaceuticals Limited opened for public subscription on December 20 and will close on December 24. The issue has garnered significant interest, particularly from retail investors.
IPO Details:
- Subscription Period: December 20–24, 2024
- Price Band: ₹372–₹381 per share
- Lot Size: 38 shares per lot
- Shares on Offer: 85,34,681
Subscription Status (as of Day 3):
The Senores Pharma IPO has been subscribed 1.78 times overall, with a strong response from retail investors:
- Retail Individual Investors (RIIs): 7.20x subscription
- Non-Institutional Investors (NIIs): 1.67x subscription
- Qualified Institutional Buyers (QIBs): 0.10x subscription
A total of 1,51,86,662 shares have been bid against 85,34,681 shares on offer.
Grey Market Premium (GMP):
The grey market premium for Senores Pharmaceuticals has shown a consistent uptrend:
- December 20: ₹190
- December 22: ₹200
- December 23: ₹215
At the current GMP of ₹215, Senores Pharma shares are expected to list at ₹591 per share, reflecting a premium of 51.15% over the upper price band of ₹381.
Investor Sentiment:
Retail investors have shown overwhelming interest, driving the subscription to 7.20x for their category. Non-institutional investors and QIBs have been comparatively less aggressive, but participation is expected to increase as the issue approaches its close.
